JP2011502164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502164A5 JP2011502164A5 JP2010532233A JP2010532233A JP2011502164A5 JP 2011502164 A5 JP2011502164 A5 JP 2011502164A5 JP 2010532233 A JP2010532233 A JP 2010532233A JP 2010532233 A JP2010532233 A JP 2010532233A JP 2011502164 A5 JP2011502164 A5 JP 2011502164A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- peptide chain
- antibody
- per
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/931,201 US20090136505A1 (en) | 2005-02-23 | 2007-10-31 | Intranasal Administration of Active Agents to the Central Nervous System |
| PCT/US2008/081722 WO2009058957A2 (en) | 2007-10-31 | 2008-10-30 | Intranasal administration of active agents to the central nervous system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014126401A Division JP2014205698A (ja) | 2007-10-31 | 2014-06-19 | 活性剤の中枢神経系への鼻内投与 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011502164A JP2011502164A (ja) | 2011-01-20 |
| JP2011502164A5 true JP2011502164A5 (https=) | 2011-10-06 |
Family
ID=40591743
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532233A Pending JP2011502164A (ja) | 2007-10-31 | 2008-10-30 | 活性剤の中枢神経系への鼻内投与 |
| JP2014126401A Pending JP2014205698A (ja) | 2007-10-31 | 2014-06-19 | 活性剤の中枢神経系への鼻内投与 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014126401A Pending JP2014205698A (ja) | 2007-10-31 | 2014-06-19 | 活性剤の中枢神経系への鼻内投与 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US20090136505A1 (https=) |
| EP (2) | EP2207802A4 (https=) |
| JP (2) | JP2011502164A (https=) |
| WO (1) | WO2009058957A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910101B2 (en) * | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| KR100785656B1 (ko) * | 2007-05-14 | 2007-12-17 | 재단법인서울대학교산학협력재단 | 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체 |
| EP2769711A1 (en) | 2008-07-10 | 2014-08-27 | ESBATech, an Alcon Biomedical Research Unit LLC | Methods and Compositions for Enhanced Delivery of Macromolecules |
| CN102933198B (zh) * | 2009-09-25 | 2015-10-07 | 雷迪博士实验室有限公司 | 包含曲普坦化合物的制剂 |
| US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
| DK2480197T3 (en) | 2009-09-25 | 2016-01-25 | Reddys Lab Ltd Dr | Compositions containing triptanforbindelser |
| US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
| US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
| EP2646468B1 (en) | 2010-12-01 | 2018-07-25 | AlderBio Holdings LLC | Anti-ngf compositions and use thereof |
| US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
| US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
| US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
| US8609088B2 (en) | 2011-05-10 | 2013-12-17 | Regents Of The University Of Minnesota | Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases |
| US10016473B2 (en) | 2012-08-17 | 2018-07-10 | Howard University | Method, apparatus, and kit for the pulsing treatment of neurodegenerative diseases and impairments |
| US9101652B2 (en) | 2012-08-17 | 2015-08-11 | Howard University | Method, apparatus and kit for the treatment of neurodegenerative diseases and impairments |
| SI2961426T1 (sl) | 2013-02-26 | 2020-01-31 | Baxalta GmbH | Zdravljanje motenj centralnega živčnega sistema z intranazalnim dajanjem imunoglobulina G |
| HUE044737T2 (hu) | 2013-05-06 | 2019-11-28 | Baxalta Inc | Alzheimer-kór szubpopulációk kezelése egyesített immunglubulin G-vel |
| CN115120746A (zh) | 2013-05-15 | 2022-09-30 | 明尼苏达大学董事会 | 腺相关病毒介导的基因向中枢神经系统转移 |
| WO2017136376A1 (en) * | 2016-02-01 | 2017-08-10 | The University Of North Carolina At Chapel Hill | Polyelectrolyte complexes for delivery of agents to the cns |
| SG10201912761UA (en) | 2016-04-15 | 2020-02-27 | The Trustees Of The Univ Of Pennsyvania | Gene therapy for treating mucopolysaccharidosis type ii |
| KR102883778B1 (ko) | 2017-09-22 | 2025-11-12 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | Ii형 점액다당류증의 치료를 위한 유전자 요법 |
| BR112020013749A2 (pt) * | 2018-01-05 | 2020-12-01 | Impel Neuropharma, Inc. | dispensação intranasal de pó de levodopa por dispositivo olfativo de precisão |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4476116A (en) * | 1982-12-10 | 1984-10-09 | Syntex (U.S.A.) Inc. | Polypeptides/chelating agent nasal compositions having enhanced peptide absorption |
| KR850004274A (ko) * | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
| FR2598081B1 (fr) * | 1986-04-30 | 1990-02-02 | Chauvin Blache Lab | Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique |
| GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) * | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5856298A (en) * | 1989-10-13 | 1999-01-05 | Amgen Inc. | Erythropoietin isoforms |
| CA2070823C (en) | 1989-12-05 | 1999-01-12 | William H. Ii Frey | Neurologic agents for nasal administration to the brain |
| ATE158021T1 (de) * | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5545806A (en) * | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| GB9020544D0 (en) * | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5661130A (en) | 1993-06-24 | 1997-08-26 | The Uab Research Foundation | Absorption enhancers for drug administration |
| US5830853A (en) * | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
| WO1995011042A1 (en) | 1993-10-21 | 1995-04-27 | Hisamitsu Pharmaceutical Co., Inc. | Pernasal composition and pernasal preparation containing the same |
| JP3597233B2 (ja) * | 1993-10-21 | 2004-12-02 | 久光製薬株式会社 | 経鼻組成物及びそれを含有する経鼻製剤 |
| US5897858A (en) * | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
| BR9606838A (pt) | 1995-01-23 | 1999-11-30 | Direct Haler A S | Inalador |
| DE19544393A1 (de) | 1995-11-15 | 1997-05-22 | Hoechst Schering Agrevo Gmbh | Synergistische herbizide Mischungen |
| GB9700624D0 (en) * | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
| IT1289608B1 (it) | 1997-02-05 | 1998-10-15 | Angelini Ricerche Spa | Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale |
| US6235883B1 (en) * | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| US6750324B1 (en) * | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
| US6761888B1 (en) * | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| ES2252993T3 (es) | 1998-12-09 | 2006-05-16 | Chiron Corporation | Administracion de agentes neurotroficos al sistema nervioso central. |
| US7273618B2 (en) * | 1998-12-09 | 2007-09-25 | Chiron Corporation | Method for administering agents to the central nervous system |
| EP1135105B1 (en) | 1998-12-09 | 2005-03-02 | Chiron Corporation | Use of a neurologic agent for the manufacture of a medicament for the treatment of a central nervous system disorder |
| CN1736502A (zh) * | 1999-03-03 | 2006-02-22 | 奥普蒂诺斯公司 | 鼻传送装置 |
| MXPA02001417A (es) | 1999-08-09 | 2002-08-12 | Lexigen Pharm Corp | Complejos multiples de citosina-anticuerpo. |
| US6824780B1 (en) * | 1999-10-29 | 2004-11-30 | Genentech, Inc. | Anti-tumor antibody compositions and methods of use |
| GB0007850D0 (en) | 2000-03-31 | 2000-05-17 | Microbiological Res Authority | Passive and active protection against mycobacterial infections |
| WO2001082902A1 (en) * | 2000-04-28 | 2001-11-08 | Zengen, Inc. | Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane |
| KR20030074693A (ko) * | 2000-12-28 | 2003-09-19 | 알투스 바이올로직스 인코포레이티드 | 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법 |
| AU2002303159A1 (en) * | 2001-03-26 | 2002-10-08 | Linden Technologies, Inc. | Polymer synthesis |
| US20040028613A1 (en) * | 2001-06-25 | 2004-02-12 | Nastech Pharmaceutical Company Inc | Dopamine agonist formulations for enhanced central nervous system delivery |
| US20070004743A1 (en) | 2002-02-25 | 2007-01-04 | Xiao Linda L | Intranasal administration of mc4-r agonists |
| US20040115153A1 (en) * | 2002-12-17 | 2004-06-17 | L'oreal | Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one silicone gum and methods of using the same |
| US7241733B2 (en) | 2002-06-28 | 2007-07-10 | Centocor, Inc. | Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| US7166575B2 (en) * | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| US6734427B1 (en) * | 2003-02-14 | 2004-05-11 | United Microelectronics Corp. | TEM/SEM sample preparation |
| GB0315632D0 (en) * | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
| US20060188496A1 (en) * | 2005-02-23 | 2006-08-24 | Hanne Bentz | Intranasal administration of active agents to the central nervous system |
| WO2007016562A2 (en) * | 2005-07-29 | 2007-02-08 | Amgen Inc. | Formulations that inhibit protein aggregation |
| WO2008023050A1 (en) * | 2006-08-25 | 2008-02-28 | Novo Nordisk A/S | Acylated exendin-4 compounds |
| CA2667466A1 (en) * | 2006-10-27 | 2008-05-02 | Ablynx N.V. | Intranasal delivery of polypeptides and proteins |
-
2007
- 2007-10-31 US US11/931,201 patent/US20090136505A1/en not_active Abandoned
-
2008
- 2008-10-30 JP JP2010532233A patent/JP2011502164A/ja active Pending
- 2008-10-30 EP EP08843471A patent/EP2207802A4/en not_active Withdrawn
- 2008-10-30 WO PCT/US2008/081722 patent/WO2009058957A2/en not_active Ceased
- 2008-10-30 EP EP13181567.2A patent/EP2668940A1/en not_active Withdrawn
-
2010
- 2010-11-24 US US12/954,219 patent/US8883728B2/en active Active
-
2014
- 2014-06-19 JP JP2014126401A patent/JP2014205698A/ja active Pending
- 2014-09-24 US US14/495,291 patent/US9732147B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011502164A5 (https=) | ||
| Waldmann et al. | A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza | |
| Crivianu-Gaita et al. | Aptamers, antibody scFv, and antibody Fab'fragments: An overview and comparison of three of the most versatile biosensor biorecognition elements | |
| Lee et al. | Amplified protein detection and identification through DNA-conjugated M13 bacteriophage | |
| US8900590B2 (en) | Anti-hemagglutinin antibody compositions and methods of use thereof | |
| KR20230016184A (ko) | 코로나바이러스에 대한 변이체 핵산 라이브러리 | |
| JP2018033454A5 (https=) | ||
| US11740236B2 (en) | Protein for rapid, efficient capture of antigens | |
| FI4074331T3 (fi) | Koostumuksia ja menetelmiä entsyymien internalisoimiseksi | |
| US20160291007A1 (en) | Polynucleotide conjugates and methods for analyte detection | |
| JP6029586B2 (ja) | 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法 | |
| JP5886194B2 (ja) | インフルエンザ感染の診断および／または処置のための組成物および方法 | |
| Maquieira et al. | Aluminum oxide nanoparticles as carriers and adjuvants for eliciting antibodies from non-immunogenic haptens | |
| JP5582483B2 (ja) | 一本鎖抗体、固相、遺伝子、ベクター及び宿主 | |
| JP2012525432A5 (https=) | ||
| CN116033926A (zh) | 针对ace2靶向病毒可用的结合蛋白 | |
| JP2010502207A5 (https=) | ||
| RU2010127156A (ru) | Антитела против вируса гриппа и их применение | |
| JP2010521147A5 (https=) | ||
| US11987616B2 (en) | Antigen binding molecules targeting SARS-CoV-2 | |
| JP2012509900A5 (https=) | ||
| Hidari et al. | Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection | |
| US12043862B2 (en) | High-throughput serotyping and antibody profiling assays | |
| JP2014530008A (ja) | ヒトｂ細胞で生産されたインフルエンザａウイルス中和活性を持つ結合分子 | |
| AU2018202468A1 (en) | Agents for influenza neutralization |